The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

@article{Pliszka2006TheTC,
  title={The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.},
  author={Steven R. Pliszka and M. Lynn Crismon and Carroll W. Hughes and C Keith Corners and Graham J. Emslie and Peter S. Jensen and James T. McCracken and James M. Swanson and Molly Lopez},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2006},
  volume={45 6},
  pages={
          642-57
        }
}
OBJECTIVE In 1998, the Texas Department of Mental Health and Mental Retardation developed algorithms for medication treatment of attention-deficit/hyperactivity disorder (ADHD). Advances in the psychopharmacology of ADHD and results of a feasibility study of algorithm use in community mental health centers caused the algorithm to be modified and updated. METHOD We convened a consensus conference of academic clinicians and researchers, practicing clinicians, administrators, consumers, and… 
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
TLDR
Evidence and expert clinical consensus support the use of selected antidepressants in the treatment of depression in youths, and appropriate monitoring of suicidality and potential adverse effects is required.
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project.
TLDR
The high rates of symptomatic remission observed within this clinical service may be a function of adherence to CMAP recommendations, and additional investigations of the impacts of implementing evidence-based guidelines are critically needed.
Clinical Practice Guideline for the Diagnosis , Evaluation , and Treatment of Attention-De fi cit / Hyperactivity Disorder in Children and Adolescents
TLDR
A companion article was created on systemic barriers to the care of children and adolescents with ADHD, which identifies the major systemic-level barriers and presents recommendations to address those barriers and support the recommendations of the clinical practice guideline and accompanying process of care algorithm.
Treatment of Attention Deficit Hyperactivity Disorder in Children With Medical Comorbidities
TLDR
Medications, including D,L-methylphenidate (MPH), dextroamphetamine, mixed amphetamine salts, and atomoxetine are FDA approved for the treatment of ADHD and considered first-line treatments, and these agents were very effective in treating symptoms of ADHD.
Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
TLDR
Sociodemographic, clinical, and provider characteristics are associated with initial treatment for youths with ADHD, and more evidence on psychotropic safety and efficacy is needed considering the high prevalence of concomitant mental disorders, multidrug regimens, and off-label use.
Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review
TLDR
Results of this study revealed that atomoxetine is effective both in ADHD/I and ADHD/C subtypes, and that ADHD/ C types responded better to medication.
Clinical Practice Guidelines for Attention-Deficit/Hyperactivity Disorder: A Review
  • O. Bukstein
  • Medicine, Psychology
    Postgraduate medicine
  • 2010
TLDR
9 clinical practice guidelines for ADHD are reviewed, finding that a patient-centered approach is also recommended in the evaluation and treatment of ADHD, although it is less evidence based than recommended therapies.
Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway
  • D. Coghill, S. Seth
  • Medicine, Psychology
    Child and Adolescent Psychiatry and Mental Health
  • 2015
TLDR
The Dundee ADHD Clinical Care Pathway (DACCP) uses standard protocols for assessment, titration and routine monitoring of clinical care and treatment outcomes, with much of the clinical work being nurse led.
Changes and challenges: managing ADHD in a fast-paced world.
TLDR
The pathophysiology of ADHD is linked to dysfunction of fronto-subcortical networks and dysregulation of dopaminergic, noradrenergic, and nicotinic neurotransmitter systems, which contributes to the clinical picture.
Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with fetal alcohol spectrum disorder.
TLDR
It is suggested that inattention may be less responsive to ADHD medication, and replication in larger samples with a placebo-controlled design is required.
...
...

References

SHOWING 1-10 OF 77 REFERENCES
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder.
OBJECTIVES Expert consensus methodology was used to develop evidence-based, consensually agreed-upon medication treatment algorithms for attention-deficit/hyperactivity disorder (ADHD) in the public
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder.
TLDR
Tactics for psychopharmacological management of ADHD can be developed with consensus and are designed to be practical for implementation in the public mental health sector, but they may have utility in many practice settings, including the private practice environment.
The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
  • C. Hughes, G. Emslie, A. Rush
  • Medicine, Psychology
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 1999
TLDR
Consensually agreed-upon algorithms for major depressions (with and without psychosis) and comorbid attention deficit disorders were developed and will be tested as to whether it improves clinical outcomes for children and adolescents with MDD.
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
TLDR
Children with ADHD/ANX have a response rate to stimulant for ADHD that is comparable with that of children with general ADHD, and the benefit of adding FLV to stimulants for ANX remains unproven.
ATOMOXETINE TREATMENT FOR PEDIATRIC PATIENTS WITH ADHD AND COMORBID ANXIETY
TLDR
Results suggest atomoxetine is efficacious in pediatric patients with ADHD and comorbid anxiety.
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.
TLDR
Until additional research from controlled trials becomes available, these evidence- and consensus-based treatment recommendations may be a useful approach to guide the use of antipsychotics in youth with aggression.
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
TLDR
Until additional research from controlled trials becomes available, these evidence- and consensus-based treatment recommendations may be a useful approach to guide the use of antipsychotics in youth with aggression.
A Psychoeducational Program for Children with ADHD or Depression and their Families: Results from the CMAP Feasibility Study
TLDR
The Children’s Medication Algorithm Project (CMAP) incorporated a psychoeducational program into the medication algorithm created to improve treatment of children with ADHD and/or depression in the Texas public mental health sector.
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
TLDR
Clonidine may be an effective second-tier treatment for symptoms of ADHD, but it has an effect size less than that of stimulants.
ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation
The ADHD Rating Scale-IV: Checklist, norms, and clinical interpretation (ADHD Rating Scale-IV; DuPaul, Power, Anastopoulos, & Reid, 1998) is a norm-referenced checklist that measures the symptoms of
...
...